Back
KEYENCE Corp. Vs. Nektar Therapeutics Industry Stock Comparison
Sell
49
KYCCF
KEYENCE Corp.
Last Price:
$355.00
Seasonality Move:
3.13%
Sell
33
NKTR
Nektar Therapeutics
Last Price:
$54.70
Seasonality Move:
11.58%
Sell
49
KEYENCE Corp. (KYCCF)
is a Sell
Is KEYENCE Corp. a Buy, Sell or Hold?
-
The current KEYENCE Corp. [KYCCF] share price is $354.98. The Score for KYCCF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
KYCCF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KYCCF Stock Price Chart
What is KEYENCE Corp.'s stock price today?
-
The KEYENCE Corp. share price today is $354.98The current trend is relatively stagnant and KYCCF is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $51.12The current trend is relatively stagnant and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
KYCCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.17 | Sell |
| Relative Strength Index (14 RSI): | 50.53 | Buy |
| Chaikin Money Flow: | -90 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (339.4 - 357.52) | Buy |
| Bollinger Bands (100): | (357.47 - 396.31) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 39.75 | Sell |
| Chaikin Money Flow: | -893008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.73 - 61.07) | Sell |
| Bollinger Bands (100): | (32.3 - 62.42) | Buy |
KYCCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 346.41 | Buy |
| 20-day SMA: | 345.53 | Buy |
| 50-day SMA: | 371.17 | Sell |
| 200-day SMA: | 390.78 | Sell |
| 8-day EMA: | 349.04 | Buy |
| 20-day EMA: | 350.8 | Buy |
| 50-day EMA: | 363.04 | Sell |
| 200-day EMA: | 388.68 | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.44 | Sell |
| 20-day SMA: | 58.08 | Sell |
| 50-day SMA: | 58.52 | Sell |
| 200-day SMA: | 30.43 | Buy |
| 8-day EMA: | 56.58 | Sell |
| 20-day EMA: | 57.71 | Sell |
| 50-day EMA: | 55.82 | Sell |
| 200-day EMA: | 37.69 | Buy |
KEYENCE Corp. Earnings Growth & KYCCF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
KEYENCE Corp. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||